This is an old revision of this page, as edited by LegionMammal978 (talk | contribs) at 23:29, 27 April 2021 (correct IUPAC name). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:29, 27 April 2021 by LegionMammal978 (talk | contribs) (correct IUPAC name)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Names | |
---|---|
Preferred IUPAC name methyl (3R)-3-hydroxy-2,2-dimethyl-4-({3-sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl dihydrogen diphosphate | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
MeSH | tiglyl-coenzyme+A |
PubChem CID | |
CompTox Dashboard (EPA) | |
SMILES
| |
Properties | |
Chemical formula | C26H42N7O17P3S |
Molar mass | 849.63 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
Tiglyl-CoA is an intermediate in the metabolism of isoleucine. It is an inhibitor of N-acetylglutamate synthetase.
References
- ROBINSON WG; BACHHAWAT BK; COON MJ (1956). "TIGLYL COENZYME A AND a-METHYLACETOACETYL COENZYME A, INTERMEDIATES IN THE ENZYMATIC DEGRADATION OF ISOLEUCINE". Journal of Biological Chemistry. 218 (1): 391–400. doi:10.1016/S0021-9258(18)65902-2. PMID 13278346.
- "Showing metabocard for Tiglyl-CoA (HMDB02054)". The Metabolomics Innovation Centre (TMIC).
- Coude, F X; Sweetman, L; Nyhan, W L (1979). "Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia". Journal of Clinical Investigation. 64 (6): 1544–1551. doi:10.1172/JCI109614. PMC 371306. PMID 500823.
This article about an organic compound is a stub. You can help Misplaced Pages by expanding it. |